Trademark applications and grants for Meiji Seika Pharma Co L T D. Meiji Seika Pharma Co L T D has 14 trademark applications. The latest application filed is for "a symbol or image mark"
Patent Application | Date |
---|---|
ANTIBODIES THAT BIND TO CLEAVED FORM OF MUTANT CALRETICULIN, AND DIAGNOSTIC, PREVENTIVE, OR THERAPEUTIC AGENT FOR MYELOPROLIFERATIVE NEOPLASM 20220098290 - 17/434619 ARAKI; Marito ;   et al. | 2022-03-31 |
MESOSTIGMATA MITE CONTROL COMPOSITION 20220046921 - 17/275461 NAKAMURA; Satoshi ;   et al. | 2022-02-17 |
PROCESSES FOR PREPARING A DIAZABICYCLOOCTANE COMPOUND 20210371419 - 17/399618 ABE; Takao ;   et al. | 2021-12-02 |
AQUEOUS SUSPENSION-FORM PESTICIDAL COMPOSITION 20210345612 - 17/268315 OCHIAI; Kazuko ;   et al. | 2021-11-11 |
THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, FIBROTIC DISEASES, AND CANCER DISEASES 20210315892 - 17/255560 ISHIDA; Natsuki ;   et al. | 2021-10-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.